These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1763562)

  • 1. [Effect of pellet size of a pancreas enzyme preparation on duodenal lipolytic activity].
    Kühnelt P; Mundlos S; Adler G
    Z Gastroenterol; 1991 Sep; 29(9):417-21. PubMed ID: 1763562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New methods for assessment of enzyme activity: do they help to optimize enzyme treatment?
    Adler G; Mundlos S; Kühnelt P; Dreyer E
    Digestion; 1993; 54 Suppl 2():3-9. PubMed ID: 7693531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal size range for enteric-coated pancreatin preparations.
    Lederer PC
    Pancreas; 2011 Mar; 40(2):310-1. PubMed ID: 21311309
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
    Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F
    Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test.
    Mundlos S; Kühnelt P; Adler G
    Gut; 1990 Nov; 31(11):1324-8. PubMed ID: 2253920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of enteric-coated pancreatin microsphere therapy after conventional and pylorus-preserving pancreatoduodenectomy.
    Bruno MJ; Borm JJ; Hoek FJ; Delzenne B; Hofmann AF; de Goeij JJ; van Royen EA; van Gulik TM; de Wit LT; Gouma DJ; van Leeuwen DJ; Tytgat GN
    Br J Surg; 1997 Jul; 84(7):952-6. PubMed ID: 9240133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pectin and wheat bran on intraluminal pancreatic enzyme activities and on fat absorption as examined with the triolein breath test in patients with pancreatic insufficiency.
    Isaksson G; Lundquist I; Akesson B; Ihse I
    Scand J Gastroenterol; 1984 Jun; 19(4):467-72. PubMed ID: 6205439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
    Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
    Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency.
    Halm U; Löser C; Löhr M; Katschinski M; Mössner J
    Aliment Pharmacol Ther; 1999 Jul; 13(7):951-7. PubMed ID: 10383531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis.
    Schneider MU; Knoll-Ruzicka ML; Domschke S; Heptner G; Domschke W
    Hepatogastroenterology; 1985 Apr; 32(2):97-102. PubMed ID: 2408983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the pancreas really produce much more lipase than required for fat digestion?
    Carrière F; Grandval P; Gregory PC; Renou C; Henniges F; Sander-Struckmeier S; Laugier R
    JOP; 2005 May; 6(3):206-15. PubMed ID: 15883471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis.
    Bruno MJ; Borm JJ; Hoek FJ; Delzenne B; Hofmann AF; de Goeij JJ; van Royen EA; van Leeuwen DJ; Tytgat GN
    Dig Dis Sci; 1998 Jan; 43(1):203-13. PubMed ID: 9508526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of oral enzymes in pancreatic insufficiency.
    Guarner L; Rodríguez R; Guarner F; Malagelada JR
    Gut; 1993 May; 34(5):708-12. PubMed ID: 8504976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dose-dependent effect of pancreatin replacement upon the pancreatic function in the period after pancreatic surgery].
    Farkas G; Leindler L; Mihalovits G
    Magy Seb; 2001 Dec; 54(6):347-50. PubMed ID: 11816130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
    Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nonpancreatic lipolytic activity in exocrine pancreatic insufficiency.
    Abrams CK; Hamosh M; Dutta SK; Hubbard VS; Hamosh P
    Gastroenterology; 1987 Jan; 92(1):125-9. PubMed ID: 3781179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.